Briol, Tertulo M.

HRN: 22-75-14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
CEFTRIAXONE 1G (VIAL)
03/15/2023
03/22/2023
IV
2gms
OD
Erysieplas; H Pylori
Waiting Final Action 
03/16/2023
AMOXICILLIN 500MG CAPSULE (CAP)
03/16/2023
03/23/2023
PO
500mg
BID
H. Pylori
Waiting Final Action 
03/16/2023
CLARITHROMYCIN 500MG (CAP)
03/16/2023
03/23/2023
PO
500mg
BID
H. Pylori Infection
Waiting Final Action 
03/16/2023
CLINDAMYCIN 300MG (CAP)
03/16/2023
03/23/2023
PO
300mg
TID
Cellulitis Facial Area
Waiting Final Action 
03/16/2023
ACICLOVIR 800MG (TAB)
03/16/2023
03/23/2023
PO
800mg
5x A Day
Malignant Otitis Media Vs RHS
Waiting Final Action 
03/16/2023
MUPIROCIN 2%, 15G (TUBE)
03/16/2023
03/23/2023
TOPICAL
15g
Bid
Malignant Otitis Media Vs RHS
Waiting Final Action 
03/16/2023
CIPROFLOXACIN 500MG (TAB)
03/16/2023
03/22/2023
PO
500 Mg
BID
Malignant Otitis Media
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: